256 related articles for article (PubMed ID: 15724150)
1. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity.
Krogsgaard M; Li QJ; Sumen C; Huppa JB; Huse M; Davis MM
Nature; 2005 Mar; 434(7030):238-43. PubMed ID: 15724150
[TBL] [Abstract][Full Text] [Related]
2. Direct observation of ligand recognition by T cells.
Irvine DJ; Purbhoo MA; Krogsgaard M; Davis MM
Nature; 2002 Oct; 419(6909):845-9. PubMed ID: 12397360
[TBL] [Abstract][Full Text] [Related]
3. Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response.
Rogers PR; Grey HM; Croft M
J Immunol; 1998 Apr; 160(8):3698-704. PubMed ID: 9558070
[TBL] [Abstract][Full Text] [Related]
4. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
5. Multispecific responses by T cells expanded by endogenous self-peptide/MHC complexes.
Cai G; Hafler DA
Eur J Immunol; 2007 Mar; 37(3):602-12. PubMed ID: 17304631
[TBL] [Abstract][Full Text] [Related]
6. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
[TBL] [Abstract][Full Text] [Related]
7. Selective functional depletion of HIV gp120 peptides complexed with MHC from antigen-presenting cells engaged with specific T lymphocytes.
Manca F
J Immunol; 1992 Aug; 149(3):796-800. PubMed ID: 1634769
[TBL] [Abstract][Full Text] [Related]
8. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.
Kao C; Daniels MA; Jameson SC
Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755
[TBL] [Abstract][Full Text] [Related]
9. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes.
Malarkannan S; Goth S; Buchholz DR; Shastri N
J Immunol; 1995 Jan; 154(2):585-98. PubMed ID: 7814870
[TBL] [Abstract][Full Text] [Related]
10. Small molecule modulators of MHC class II antigen presentation: mechanistic insights and implications for therapeutic application.
Call MJ
Mol Immunol; 2011 Sep; 48(15-16):1735-43. PubMed ID: 21676462
[TBL] [Abstract][Full Text] [Related]
11. The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells.
Haug M; Dannecker L; Schepp CP; Kwok WW; Wernet D; Buckner JH; Kalbacher H; Dannecker GE; Holzer U
Eur J Immunol; 2005 Nov; 35(11):3163-72. PubMed ID: 16245362
[TBL] [Abstract][Full Text] [Related]
12. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse.
Li QJ; Dinner AR; Qi S; Irvine DJ; Huppa JB; Davis MM; Chakraborty AK
Nat Immunol; 2004 Aug; 5(8):791-9. PubMed ID: 15247914
[TBL] [Abstract][Full Text] [Related]
13. Ito cells are liver-resident antigen-presenting cells for activating T cell responses.
Winau F; Hegasy G; Weiskirchen R; Weber S; Cassan C; Sieling PA; Modlin RL; Liblau RS; Gressner AM; Kaufmann SH
Immunity; 2007 Jan; 26(1):117-29. PubMed ID: 17239632
[TBL] [Abstract][Full Text] [Related]
14. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
[TBL] [Abstract][Full Text] [Related]
15. Feedback activation of T-cell antigen-presenting cells during interactions with T-cell responders.
Mannie MD; Walker MR
J Leukoc Biol; 2001 Aug; 70(2):252-60. PubMed ID: 11493617
[TBL] [Abstract][Full Text] [Related]
16. Immunosynapse formation coincides with rapid activation of NK cells by syngeneic T cells and correlates with clustering of MHC class I.
Rabinovich BA; Li J; Hurren R; Miller RG
Int Immunol; 2005 Jun; 17(6):671-6. PubMed ID: 15899925
[TBL] [Abstract][Full Text] [Related]
17. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.
Felix NJ; Donermeyer DL; Horvath S; Walters JJ; Gross ML; Suri A; Allen PM
Nat Immunol; 2007 Apr; 8(4):388-97. PubMed ID: 17322886
[TBL] [Abstract][Full Text] [Related]
18. The CD8 beta polypeptide is required for the recognition of an altered peptide ligand as an agonist.
Renard V; Delon J; Luescher IF; Malissen B; Vivier E; Trautmann A
Eur J Immunol; 1996 Dec; 26(12):2999-3007. PubMed ID: 8977296
[TBL] [Abstract][Full Text] [Related]
19. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.
Sant AJ; Chaves FA; Jenks SA; Richards KA; Menges P; Weaver JM; Lazarski CA
Immunol Rev; 2005 Oct; 207():261-78. PubMed ID: 16181342
[TBL] [Abstract][Full Text] [Related]
20. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.
Lazarski CA; Chaves FA; Jenks SA; Wu S; Richards KA; Weaver JM; Sant AJ
Immunity; 2005 Jul; 23(1):29-40. PubMed ID: 16039577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
